CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Italy


Posted December 7, 2016 by Shirley

The report is an essential source of information and analysis on Italy’s healthcare, regulatory and reimbursement landscape.

 
MRRS adds "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Italy" latest studies, published in Nov 2016.

Summary
GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Italy”. The report is an essential source of information and analysis on Italy’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and the country’s healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the Italian pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.
Italy’s population was 61.78 million in 2015, and is increasing due to a positive balance between the birth and death rates, as well as through immigration. The country’s policymakers are currently faced with the challenge of an increasing unemployment rate due to a lack of clear monetary policies. The pharmaceutical market at the consumer price level (including Value Added Tax (VAT) and excluding hospital sales) was estimated at $22 billion in 2015, and is expected to decline to approximately $18 billion by 2020, at a negative Compound Annual Growth Rate (CAGR) of 3.3%. The medical devices market was estimated at approximately $13.2 billion in 2015, and is expected to reach $16.2 billion by 2020, at a CAGR of 4.2%. The decline of Italy’s pharmaceutical market can primarily be attributed to –
– Owing to government measures to decrease healthcare expenditure
– Falling sales of patented drugs,
– Price cuts for drugs
– Government initiatives to promote generics
– The strict pricing of drugs through negotiations and through external reference pricing and internal reference pricing

Table of Contents
1 Table of Contents 7
2 Introduction 20
2.1 GlobalData Report Guidance 20
3 Overview of Pharmaceutical and Medical Device Markets 21
3.1 Pharmaceutical Market 21
3.1.1 Market Overview 21
3.1.2 Pharmaceutical Import and Export 23
3.1.3 Supply Channels 25
3.1.4 Market Segments 26
3.1.5 Major Therapeutic Areas 31
3.1.6 Major Companies 34
3.2 Medical Device Market 74
3.2.1 Market Overview 74
3.2.2 Overview of Top Five Segments 76
3.2.3 Diagnostic Market 87
3.2.4 Major Companies 89
3.3 Market Drivers and Barriers 125
3.3.1 Drivers 125
3.3.2 Barriers 127
4 Market Access 130
4.1 Reimbursement and Payer Landscape 130
4.1.1 Overview of Healthcare system 130
4.1.2 Evolution of Healthcare System in Italy 135
4.1.3 Reimbursement Process 138
4.1.4 Overview of Insurance Providers 144
4.1.5 Patient Share in Healthcare Spending 146
4.1.6 Price Trends in the Healthcare Sector 149
4.1.7 Pricing Policies 150
4.2 Regulatory Landscape 152...

List of Tables and Figures
Table 1: Pharmaceutical Market, Italy, Revenue ($bn), 2008-2015 22
Table 2: Pharmaceutical Market, Italy, Revenue ($bn), 2016-2020 23
Table 3: Pharmaceutical Market, Italy, Imports and Exports ($bn), 2008-2015 24
Table 4: Pharmaceutical Distribution Channel, Italy, Price Margins (%), 2014 26
Table 5: OTC Market, Italy, Revenue ($bn) 2008-2015 29
Table 6: OTC Market, Italy, Revenue ($m) and Market Share (%) by Segment, 2014 30
Table 7: Pharmaceutical Market, Italy, Healthcare Costs by Therapeutic Area ($bn), 2014 31
Table 8: Menarini, Global, Major Products 36
Table 9: Menarini, Late-Stage Pipeline, 2014 37
Table 10: Angelini, Global, Major Products 43
Table 11: Angelini, Late-Stage Pipeline, 2016 45
Table 12: Chiesi, Global, Major Products 51
Table 13: Chiesi, Late-Stage Pipeline, 2014 54
Table 14: Bracco, Global, Major Products 61
Table 15: Recordati, Global, Major Products 70
Table 16: Recordati, Late-Stage Pipeline, 2016 74
Table 17: Medical Device Market, Italy, Revenue ($bn), 2008-2015 75
Table 18: Medical Device Market, Italy, Revenue ($bn), 2016-2020 76..

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/countryfocus-healthcare-regulatory-and-reimbursement-landscape-italy

Ask a sample or any futher questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Reports , Research
Last Updated December 7, 2016